AVDL logo

Avadel Pharmaceuticals plc (AVDL) Accounts payable

annual accounts payable:

$7.33M-$4.11M(-35.90%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual accounts payable is $7.33 million, with the most recent change of -$4.11 million (-35.90%) on December 31, 2024.
  • During the last 3 years, AVDL annual accounts payable has fallen by -$351.00 thousand (-4.57%).
  • AVDL annual accounts payable is now -36.26% below its all-time high of $11.50 million, reached on December 31, 2005.

Performance

AVDL Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

quarterly accounts payable:

$10.11M+$998.00K(+10.95%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly accounts payable is $10.11 million, with the most recent change of +$998.00 thousand (+10.95%) on June 1, 2025.
  • Over the past year, AVDL quarterly accounts payable has increased by +$320.00 thousand (+3.27%).
  • AVDL quarterly accounts payable is now -46.66% below its all-time high of $18.96 million, reached on March 31, 2024.

Performance

AVDL quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AVDL Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-35.9%+3.3%
3 y3 years-4.6%+38.2%
5 y5 years+20.1%+107.3%

AVDL Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-35.9%at low-46.7%+308.0%
5 y5-year-35.9%+149.8%-46.7%+308.0%
alltimeall time-36.3%+508.1%-46.7%+850.6%

AVDL Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$10.11M(+10.9%)
Mar 2025
-
$9.12M(+24.4%)
Dec 2024
$7.33M(-35.9%)
$7.33M(-7.4%)
Sep 2024
-
$7.92M(-19.2%)
Jun 2024
-
$9.79M(-48.3%)
Mar 2024
-
$18.96M(+65.8%)
Dec 2023
$11.43M(+44.9%)
$11.43M(-13.8%)
Sep 2023
-
$13.26M(+12.5%)
Jun 2023
-
$11.79M(+17.6%)
Mar 2023
-
$10.02M(+27.0%)
Dec 2022
$7.89M(+2.7%)
$7.89M(+218.3%)
Sep 2022
-
$2.48M(-66.1%)
Jun 2022
-
$7.32M(+21.0%)
Mar 2022
-
$6.05M(-21.2%)
Dec 2021
$7.68M(+161.7%)
$7.68M(+11.7%)
Sep 2021
-
$6.87M(+34.4%)
Jun 2021
-
$5.12M(+81.2%)
Mar 2021
-
$2.82M(-3.7%)
Dec 2020
$2.93M(-51.9%)
$2.93M(+10.3%)
Sep 2020
-
$2.66M(-45.5%)
Jun 2020
-
$4.88M(-28.1%)
Mar 2020
-
$6.79M(+11.3%)
Dec 2019
$6.10M(+74.1%)
$6.10M(+72.4%)
Sep 2019
-
$3.54M(-26.3%)
Jun 2019
-
$4.80M(+15.6%)
Mar 2019
-
$4.15M(+18.5%)
Dec 2018
$3.50M(-53.1%)
$3.50M(-69.3%)
Sep 2018
-
$11.40M(+2.1%)
Jun 2018
-
$11.17M(-29.8%)
Mar 2018
-
$15.91M(+112.7%)
Dec 2017
$7.48M(+5.2%)
$7.48M(-12.7%)
Sep 2017
-
$8.56M(-30.5%)
Jun 2017
-
$12.32M(+54.7%)
Mar 2017
-
$7.96M(+12.1%)
Dec 2016
$7.11M(+40.7%)
$7.11M(-20.8%)
Sep 2016
-
$8.97M(+27.3%)
Jun 2016
-
$7.04M(-60.2%)
Mar 2016
-
$17.67M(+67.3%)
Dec 2015
$5.05M(-37.1%)
$10.56M(+16.9%)
Mar 2015
-
$9.04M(+12.6%)
Dec 2014
$8.02M
$8.02M(+14.5%)
Sep 2014
-
$7.01M(+13.6%)
Jun 2014
-
$6.17M(-3.0%)
DateAnnualQuarterly
Mar 2014
-
$6.36M(+24.7%)
Dec 2013
$5.10M(+41.8%)
$5.10M(+23.9%)
Sep 2013
-
$4.12M(+25.9%)
Jun 2013
-
$3.27M(-4.6%)
Mar 2013
-
$3.42M(-4.8%)
Dec 2012
$3.60M(-8.3%)
$3.60M(-24.4%)
Jun 2012
-
$4.76M(+1.8%)
Mar 2012
-
$4.67M(+19.3%)
Dec 2011
$3.92M(-20.7%)
$3.92M(+14.2%)
Sep 2011
-
$3.43M(-13.8%)
Jun 2011
-
$3.98M(-15.4%)
Mar 2011
-
$4.71M(-4.8%)
Dec 2010
$4.94M(-22.4%)
$4.94M(-4.2%)
Sep 2010
-
$5.16M(-19.0%)
Dec 2009
$6.37M(+10.5%)
$6.37M(+10.5%)
Dec 2008
$5.76M(-32.8%)
$5.76M(-32.8%)
Dec 2007
$8.57M(-11.7%)
$8.57M(-33.8%)
Sep 2007
-
$12.93M(-1.1%)
Jun 2007
-
$13.07M(+27.5%)
Mar 2007
-
$10.25M(+5.7%)
Dec 2006
$9.70M(-15.6%)
$9.70M(-15.6%)
Dec 2005
$11.50M(+19.0%)
$11.50M(+3.9%)
Sep 2005
-
$11.07M(-28.5%)
Jun 2005
-
$15.49M(+98.3%)
Mar 2005
-
$7.81M(-19.1%)
Dec 2004
$9.66M(+119.7%)
$9.66M(+38.8%)
Sep 2004
-
$6.96M(0.0%)
Jun 2004
-
$6.96M(-0.8%)
Mar 2004
-
$7.02M(+59.7%)
Dec 2003
$4.40M(+232.6%)
$4.40M(+86.6%)
Sep 2003
-
$2.36M(-1.3%)
Jun 2003
-
$2.39M(+9.3%)
Mar 2003
-
$2.18M(+65.2%)
Dec 2002
$1.32M(+9.7%)
$1.32M(+24.2%)
Sep 2002
-
$1.06M(-11.7%)
Dec 2001
$1.21M(-21.8%)
$1.21M(-21.8%)
Dec 2000
$1.54M(+1.4%)
$1.54M(+1.4%)
Dec 1999
$1.52M(-41.5%)
$1.52M(-41.5%)
Dec 1998
$2.60M(+3.9%)
$2.60M(-7.2%)
Mar 1998
-
$2.80M(+12.0%)
Dec 1997
$2.50M(-19.4%)
$2.50M(-19.4%)
Dec 1996
$3.10M
$3.10M(+55.0%)
Mar 1996
-
$2.00M

FAQ

  • What is Avadel Pharmaceuticals plc annual accounts payable?
  • What is the all time high annual accounts payable for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual accounts payable year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly accounts payable year-on-year change?

What is Avadel Pharmaceuticals plc annual accounts payable?

The current annual accounts payable of AVDL is $7.33M

What is the all time high annual accounts payable for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual accounts payable is $11.50M

What is Avadel Pharmaceuticals plc annual accounts payable year-on-year change?

Over the past year, AVDL annual accounts payable has changed by -$4.11M (-35.90%)

What is Avadel Pharmaceuticals plc quarterly accounts payable?

The current quarterly accounts payable of AVDL is $10.11M

What is the all time high quarterly accounts payable for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly accounts payable is $18.96M

What is Avadel Pharmaceuticals plc quarterly accounts payable year-on-year change?

Over the past year, AVDL quarterly accounts payable has changed by +$320.00K (+3.27%)
On this page